Drug approval process in India and Europe

Journal Title: International Journal of Drug Regulatory Affairs - Year 2019, Vol 7, Issue 1

Abstract

Every time a new drug is developed it requires a great amount of research work in manufacturing, Pre- clinical Science, Controls, Chemistry & Clinical trials. Regulatory agencies have Drug Reviewers who has the responsibility of checking that whether the data supports the Safety, Effectiveness and Quality control of a New Drug product to serve the public health. Every country has its own Regulatory agency which is responsible for regulating all the Rules and Regulations and forms the guidelines for regulating the Manufacturing, Processing and Marketing of the Drugs. This Article focuses on Drug Approval Process in Europe and India.

Authors and Affiliations

S P Yamini Kanti, Ildiko Csoka, Amrish Chandra, Vikesh Kumar Shukla

Keywords

Related Articles

LIPOSOME AS A DRUG DELIVERY CARRIER-A REVIEW

The evolution of the science and technology of liposomes as a drug carrier has passed through a number of distinct phases. Because they exhibit peculiar properties due to their structure, chemical composition amphiphilic...

MEDICINES HARMONIZATION IN WEST AFRICAN ECONOMIC AND MONETARY UNION (WAEMU) COUNTRIES

With the blessing of WHO, the different regions of West Africa engaged in Pharmaceutical regulation harmonization processes on the continent. Indeed, In west Africa, WAEMU actions on the matter ended in the production of...

Informed Consent form in Clinical Trial

Informed consent form is a vital requirement for research study on the human participant. It is the consent which is given by the subject before participate in clinical trial. Informed consent mainly came in existence af...

EMERGING TRENDS IN ORAL BIOAVAILABILITY ENHANCEMENT

Oral route is one of the most accepted and convenient mode of drug administration, however low oral bioavailability of many drugs is a major concern which limits their oral administration. Optimum solubility and permeati...

HARMONIZATION & ADVANCEMENT IN PHARMACEUTICAL INDUSTRY

The urgent requirement to rationalize and harmonize regulation was impelled by instance of rising cost of Health care, Research and Development and need to meet the public requirement to approach for the safe and efficac...

Download PDF file
  • EP ID EP495760
  • DOI 10.22270/ijdra.v7i1.304
  • Views 106
  • Downloads 0

How To Cite

S P Yamini Kanti, Ildiko Csoka, Amrish Chandra, Vikesh Kumar Shukla (2019). Drug approval process in India and Europe. International Journal of Drug Regulatory Affairs, 7(1), 34-40. https://europub.co.uk/articles/-A-495760